Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.040 | 10 | 113721259 | intron variant | C/T | snv | 0.23 |
|
Skin and Connective Tissue Diseases | 0.800 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 10 | 113728572 | intron variant | G/A | snv | 0.23 |
|
Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.807 | 0.160 | 10 | 113729393 | missense variant | C/G | snv | 0.26 | 0.23 |
|
Neoplasms; Respiratory Tract Diseases | 0.030 | 1.000 | 3 | 2009 | 2013 | ||||||
|
0.807 | 0.160 | 10 | 113729393 | missense variant | C/G | snv | 0.26 | 0.23 |
|
Neoplasms; Respiratory Tract Diseases | 0.030 | 1.000 | 3 | 2009 | 2013 | ||||||
|
0.807 | 0.160 | 10 | 113729393 | missense variant | C/G | snv | 0.26 | 0.23 |
|
Neoplasms; Respiratory Tract Diseases | 0.030 | 1.000 | 3 | 2009 | 2013 | ||||||
|
1.000 | 0.120 | 10 | 113729408 | missense variant | G/A | snv | 0.26 | 0.23 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.020 | 0.500 | 2 | 2007 | 2008 | ||||||
|
0.807 | 0.160 | 10 | 113729393 | missense variant | C/G | snv | 0.26 | 0.23 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2009 | 2012 | ||||||
|
0.925 | 0.080 | 10 | 113729891 | 3 prime UTR variant | T/G | snv | 0.38 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.080 | 10 | 113729891 | 3 prime UTR variant | T/G | snv | 0.38 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.080 | 10 | 113678707 | upstream gene variant | G/A | snv | 0.11 |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.080 | 10 | 113678707 | upstream gene variant | G/A | snv | 0.11 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.925 | 0.080 | 10 | 113678707 | upstream gene variant | G/A | snv | 0.11 |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.080 | 10 | 113678707 | upstream gene variant | G/A | snv | 0.11 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.925 | 0.080 | 10 | 113710131 | intron variant | G/A | snv | 0.11 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.925 | 0.080 | 10 | 113710131 | intron variant | G/A | snv | 0.11 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.925 | 0.080 | 10 | 113730350 | 3 prime UTR variant | G/A | snv | 0.23 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.080 | 10 | 113730350 | 3 prime UTR variant | G/A | snv | 0.23 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.080 | 10 | 113730301 | 3 prime UTR variant | G/A | snv | 0.16 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.080 | 10 | 113730301 | 3 prime UTR variant | G/A | snv | 0.16 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.827 | 0.160 | 10 | 113678445 | upstream gene variant | C/A | snv | 0.22 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.827 | 0.160 | 10 | 113678445 | upstream gene variant | C/A | snv | 0.22 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.827 | 0.160 | 10 | 113678445 | upstream gene variant | C/A | snv | 0.22 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.827 | 0.160 | 10 | 113678445 | upstream gene variant | C/A | snv | 0.22 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.827 | 0.160 | 10 | 113678445 | upstream gene variant | C/A | snv | 0.22 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.827 | 0.160 | 10 | 113678445 | upstream gene variant | C/A | snv | 0.22 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 |